DK0809695T3 - Transkriptionsfaktor E2F-5 - Google Patents

Transkriptionsfaktor E2F-5

Info

Publication number
DK0809695T3
DK0809695T3 DK95915274T DK95915274T DK0809695T3 DK 0809695 T3 DK0809695 T3 DK 0809695T3 DK 95915274 T DK95915274 T DK 95915274T DK 95915274 T DK95915274 T DK 95915274T DK 0809695 T3 DK0809695 T3 DK 0809695T3
Authority
DK
Denmark
Prior art keywords
transcription factor
murine
interact
human
disclosed
Prior art date
Application number
DK95915274T
Other languages
English (en)
Inventor
Rene Bernards
Eleonore Marielle Hijmans
Thangue Nicholas Barrie La
Original Assignee
Topotarget Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topotarget Uk Ltd filed Critical Topotarget Uk Ltd
Application granted granted Critical
Publication of DK0809695T3 publication Critical patent/DK0809695T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
DK95915274T 1995-02-14 1995-04-18 Transkriptionsfaktor E2F-5 DK0809695T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502873.4A GB9502873D0 (en) 1995-02-14 1995-02-14 Transcription factor
PCT/GB1995/000869 WO1996025494A1 (en) 1995-02-14 1995-04-18 Transcription factor - e2f-5

Publications (1)

Publication Number Publication Date
DK0809695T3 true DK0809695T3 (da) 2007-04-16

Family

ID=10769580

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95915274T DK0809695T3 (da) 1995-02-14 1995-04-18 Transkriptionsfaktor E2F-5

Country Status (12)

Country Link
US (1) US6448376B1 (da)
EP (1) EP0809695B1 (da)
JP (2) JPH11500903A (da)
AT (1) ATE348154T1 (da)
AU (1) AU701913B2 (da)
CA (1) CA2211975A1 (da)
DE (1) DE69535337T2 (da)
DK (1) DK0809695T3 (da)
ES (1) ES2279512T3 (da)
GB (1) GB9502873D0 (da)
PT (1) PT809695E (da)
WO (1) WO1996025494A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4592697A (en) * 1996-09-24 1998-04-17 Dana-Farber Cancer Institute Method of targeting malignant cells using an e2f responsive promoter
WO1998014474A1 (en) * 1996-09-30 1998-04-09 Kyowa Hakko Kogyo Co., Ltd. E2f activity inhibitory compounds
EP0860445A1 (en) 1997-02-18 1998-08-26 Hoechst Aktiengesellschaft New nucleotide sequences for the cell cycle regulated expression of structural genes
EP0859008A3 (en) * 1997-02-18 2000-04-05 Hoechst Aktiengesellschaft Nucleic acid construct for the cell cycle regulated expression of structural genes
DE69836823D1 (de) 1997-10-21 2007-02-15 Univ Glasgow Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
US6399373B1 (en) 1998-06-30 2002-06-04 Genset Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
CN1331161A (zh) * 2000-06-28 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人转录因子lcr－f19.02和编码这种多肽的多核苷酸
MX2008014097A (es) 2006-06-08 2008-11-14 Basf Plant Science Gmbh Plantas que tienen caracteristicas de crecimiento mejoradas y metodo para producir las mismas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015227A1 (en) * 1992-01-29 1993-08-05 Duke University Method of assaying for the oncogenic state of cells
DE69325383T2 (de) * 1992-10-29 1999-11-25 Medical Research Council, London Testreihenanalyse-Verfahren mit transkriptionsfaktor DP-1
WO1996015243A1 (en) 1994-11-15 1996-05-23 Prolifix Limited Transcription factor e2f-4

Also Published As

Publication number Publication date
DE69535337T2 (de) 2007-07-05
JP2006340730A (ja) 2006-12-21
JPH11500903A (ja) 1999-01-26
ES2279512T3 (es) 2007-08-16
WO1996025494A1 (en) 1996-08-22
US6448376B1 (en) 2002-09-10
DE69535337D1 (de) 2007-01-25
ATE348154T1 (de) 2007-01-15
CA2211975A1 (en) 1996-08-22
AU2221595A (en) 1996-09-04
EP0809695A1 (en) 1997-12-03
EP0809695B1 (en) 2006-12-13
GB9502873D0 (en) 1995-04-05
AU701913B2 (en) 1999-02-11
PT809695E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
DE3883551D1 (de) Druckausbalancierte Dichtung mit "S" Querschnitt.
DE69609149D1 (de) Ungesättigtes Copolymer auf Olefinbasis, seine Herstellung und seine Verwendung
NO900607D0 (no) Enzymatisk oppvaskmiddel.
DE68908313D1 (de) Klebverbaende, ihre herstellung und anwendung.
DE3785967D1 (de) Monoklonale antikoerper gegen c5a und des-arg74-c5a, ihre herstellung und ihre verwendung.
DE59105838D1 (de) Dihydroxypropylsulfoethylcellulosen, ihre Herstellung und Verwendung.
DE69535337D1 (de) Transkriptionsfaktor e2f-5
DE3583355D1 (de) Gaerungsverfahren.
FI952063A0 (fi) Peneemejä, joissa 6-metyyleeni on substituoitu, ja välituotteita
DE69111768D1 (de) Enzymatische Zusammensetzung zur Bestimmung von Äthanol.
DE68900210D1 (de) Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen.
EP0785716A4 (en) CYTOKIN DESCRIBED AS LERK6
YU31697A (sh) Varijante aprotinina sa poboljšanim svojstvima
ATE286908T1 (de) Gewebespezifische expression des retinoblastoma- proteins
ATE254659T1 (de) Mikroorganismen, ihre herstellung und verwendung
DE3685743D1 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.
DE69011856D1 (de) Herstellung von hefeextrakt.
DE3585327D1 (de) Reaktive monoazofarbstoffe, deren herstellung und verwendung.
BR9609801A (pt) Petídos cíclicos análogos de somatostina com atividade inibitória do desenvolvimento de hormónio
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
DE59007730D1 (de) Monoazofarbstoffe, ihre Herstellung und Verwendung.
DE3879328D1 (de) Stannosilikate, ihre herstellung und verwendung.
DE3671033D1 (de) Monoazofarbstoffe, ihre herstellung und verwendung.